SCHEDULE 13D

Company

Emmaus Life Sciences, Inc.

Filed

June 30, 2009

Accession Number

0000950123-09-019235

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →